QuoteMedia Inc. (QMCI) – Not Getting Revenue Traction


Wednesday, April 16, 2025

QuoteMedia is a leading software developer and cloud-based syndicator of financial market information and streaming financial data solutions to media, corporations, online brokerages, and financial services companies. The Company licenses interactive stock research tools such as streaming real-time quotes, market research, news, charting, option chains, filings, corporate financials, insider reports, market indices, portfolio management systems, and data feeds. QuoteMedia provides industry leading market data solutions and financial services for companies such as the Nasdaq Stock Exchange, TMX Group (TSX Stock Exchange), Canadian Securities Exchange (CSE), London Stock Exchange Group, FIS, U.S. Bank, Broadridge Financial Systems, JPMorgan Chase, CI Financial, Canaccord Genuity Corp., Hilltop Securities, HD Vest, Stockhouse, Zacks Investment Research, General Electric, Boeing, Bombardier, Telus International, Business Wire, PR Newswire, FolioFN, Regal Securities, ChoiceTrade, Cetera Financial Group, Dynamic Trend, Inc., Qtrade Financial, CNW Group, IA Private Wealth, Ally Invest, Inc., Suncor, Virtual Brokers, Leede Jones Gable, Firstrade Securities, Charles Schwab, First Financial, Cirano, Equisolve, Stock-Trak, Mergent, Cision, Day Trade Dash and others. Quotestream®, QModTM and Quotestream ConnectTM are trademarks of QuoteMedia. For more information, please visit www.quotemedia.com.

Michael Kupinski, Director of Research, Equity Research Analyst, Digital, Media & Technology , Noble Capital Markets, Inc.

Jacob Mutchler, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

In-line results. The company reported Q4 revenue of $4.7 million and adj. EBITDA of $0.2 million, both of which were largely in line with our estimates of $4.6 million and $0.3 million, respectively, as illustrated in Figure #1 Q4 Results. Notably, both revenue and adj. EBITDA for 2024 decreased from the prior year, which was largely attributed to key clients facing difficulties during the year and reducing spending or discontinuing services entirely.

A difficult year. During the company’s Q3 earnings call, management highlighted the loss of a large client and indicated that some of its other clients are facing financial hardship, even though management indicated that there was a strong pipeline, albeit with a long ramp-up period. As such, the year-end results were largely expected to be lackluster. 


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Longevity Health Merges with 20/20 BioLabs in Bid to Redefine Healthy Aging

Key Points:
– Longevity Health and 20/20 BioLabs to merge, forming a $99M company focused on diagnostics and healthy aging.
– 2025 revenue expected to double post-merger, driven by cross-sell opportunities and product synergies.
– Combined firm targets expanding into MedSpas, retail, and clinical settings, reflecting a hybrid approach to wellness and diagnostics.

Longevity Health Holdings (Nasdaq: XAGE) is doubling down on its ambition to lead the healthy aging and diagnostics market with the announcement of a strategic all-stock merger with 20/20 BioLabs, a provider of cutting-edge diagnostic tests for early cancer detection and chronic disease risk management. The deal, which is expected to close in Q3 2025, marks another step in Longevity’s pivot toward becoming a vertically integrated longevity-focused healthcare platform.

The merger comes just months after Longevity’s acquisition of Elevai Skincare and follows the company’s March 2025 announcement outlining a broader strategy to combine diagnostics, bio-aesthetics, and nutrition under the unifying theme “Healthy Aging, Inside and Out™.” With 20/20’s technology and distribution capabilities, Longevity is adding a diagnostics engine to its growing wellness infrastructure and positioning itself as a unique player at the intersection of science, skincare, and preventative healthcare.

Under the terms of the agreement, 20/20 shareholders will own approximately 50.1% of the combined company, with Longevity shareholders retaining 49.9%—a sign of parity and the significance of what 20/20 brings to the table. The merged company will continue to trade under the ticker “XAGE” on the Nasdaq.

Founded in Gaithersburg, Maryland, 20/20 operates a CLIA-licensed and CAP-accredited laboratory and has developed OneTest™, a multi-cancer early detection (MCED) blood test capable of identifying over a dozen tumor types for under $200. The company has already integrated its tests into wellness protocols for firefighters and military veterans and is preparing to launch a new “longevity test” this spring that evaluates inflammatory markers tied to aging and disease risk.

Financially, the merger is set to double Longevity’s expected revenue for fiscal year 2025 from $3–4 million to $7–8 million and deliver at least $1 million in operational synergies. The combined company’s equity valuation is pegged at $99 million, offering a promising growth profile in a market that increasingly values integrated health solutions.

For small-cap investors, the deal highlights an emerging investment theme: convergence in wellness, biotech, and diagnostics. Longevity is carving out a niche in a crowded but high-potential market by integrating scientific, consumer-facing products with medical-grade diagnostics. This cross-disciplinary approach could make it more resilient than standalone players focused solely on aesthetics or lab testing.

Beyond the numbers, Longevity plans to offer 20/20’s tests through its network of physicians to inform more personalized bio-aesthetic treatment plans. Conversely, 20/20 will gain access to Longevity’s customer base—including thousands of firefighters—to introduce its diagnostics in new environments, including MedSpas and retail.

Leadership will be shared post-merger. Longevity’s Rajiv Shukla will remain Chairman, while 20/20’s Jonathan Cohen will step in as CEO, underscoring a collaborative transition.

As Longevity eyes further acquisitions, this deal positions it as a unique micro-cap consolidator in the rapidly evolving healthy aging space. Investors should watch closely as the company scales up from niche science to potentially mass-market longevity solutions.

Small-Caps: Are Investors Throwing Out the Baby with the Bathwater?

The small-cap sector has taken it on the chin in recent months, with widespread fear and macro uncertainty fueling a broad selloff that’s left many fundamentally solid companies trading at multi-year lows. While this environment has caused plenty of investors to retreat to the safety of larger, more liquid names, it’s also creating potential opportunities for those with a longer-term mindset.

The Russell 2000, which tracks small-cap performance, has declined steeply this year—reflecting the risk-off tone in the market. But with this pullback comes the chance to scoop up high-quality businesses at a steep discount to their intrinsic value. Historically, moments of panic often set the stage for future gains, especially in the small-cap space where sentiment tends to swing more dramatically. Right now, the indiscriminate nature of the selling has created an environment where price and value have diverged, opening the door for patient investors to build positions in companies that have been unfairly punished.

One such example is NN, Inc. (NNBR), a precision manufacturing company that operates in sectors like automotive and medical, offering highly engineered solutions. Back in December, the stock was trading around $4, but it has since dropped to roughly $1.73. While that kind of decline might suggest something is seriously broken, the business itself continues to pursue operational improvements and efficiency gains. The company has made progress in reducing debt and focusing its portfolio, and though headwinds remain, the market appears to be pricing in a worst-case scenario. For investors who believe in industrial recovery and the power of long-term restructuring, NNBR may represent deep value.

Another name that’s been dragged down in the recent slide is 1-800-Flowers.com (FLWS). In December, this online retailer was trading near $9 per share. Fast forward to today, and it’s sitting around $5.20. Despite the decline, the underlying business remains healthy. The company continues to benefit from strong seasonal demand, and its ability to cross-sell across its various gifting platforms—ranging from floral to gourmet foods—gives it a unique edge in the e-commerce space. As consumer habits shift further toward online shopping and direct-to-door services, 1-800-Flowers stands to be a long-term winner. The current pullback may have more to do with general retail fatigue and market fear than any material weakness in the business itself.

Conduent (CNDT) rounds out the list, trading at just $2 after closing last year around $4.39. Specializing in business process outsourcing and digital workflow solutions for both government and commercial clients, Conduent has a significant contract base and recurring revenue streams that provide a level of stability often overlooked in smaller tech-enabled firms. While the company has faced its share of execution challenges, it continues to win contracts and drive efficiency through restructuring efforts. If management continues to make progress and market sentiment shifts even slightly, CNDT could see meaningful upside from these levels.

In volatile times like these, it’s easy to let fear cloud judgment. But for investors who can see past short-term noise, the current small-cap selloff may offer a rare opportunity to buy good companies on sale.

Release – Saga Communications, Inc. Announces Date and Time of 1st Quarter Earnings Release and Conference Call

Research News and Market Data on SGA

April 14, 2025 16:05 ET 

GROSSE POINTE FARMS, Mich., April 14, 2025 (GLOBE NEWSWIRE) — Saga Communications, Inc. (Nasdaq: SGA) announced today that it will release its 1st Quarter 2025 results at 9:00 a.m. EDT on Thursday, May 8, 2025. The company will be holding a conference call on the same date at 11:00 a.m. EDT. The dial-in numbers are as follows:

Domestic and International Dial-in Number: (973) 528-0008
Conference Entry Code: 530273

The Company requests that all parties that have a question that they would like to submit to the Company to please email the inquiry by 10:00 a.m. EDT on May 8, 2025, to SagaIR@sagacom.com. The Company will discuss, during the limited period of the conference call, those inquiries it deems of general relevance and interest. Only inquiries made in compliance with the foregoing will be discussed during the call.

Saga’s earnings release will contain certain non-GAAP financial measures including station operating income, trailing 12-month consolidated EBITDA, and same station financial information. A reconciliation of all non-GAAP financial measures to the most directly comparable GAAP measures will be provided in the earnings release.

Saga is a media company whose business is devoted to acquiring, developing, and operating broadcast properties with a focus on providing opportunities complimentary to our core radio business including digital, e-commerce, local on-line news services and non-traditional revenue initiatives.  Saga owns or operates broadcast properties in 28 markets, including 82 FM and 32 AM radio stations and 79 metro signals. For additional information, contact us at (313) 886-7070 or visit our website at www.sagacom.com.

Contact:
Samuel D. Bush
(313) 886-7070

Release – Alliance Resource Partners, L.P. Announces Jesse M. Parrish Will Serve as Senior Vice President of Alliance Coal, LLC

Research News and Market Data on ARLP

Apr 14, 2025 3:36 PM Eastern Daylight Time

TULSA, Okla.–(BUSINESS WIRE)–Alliance Resource Partners, L.P. (NASDAQ: ARLP) today announces that Jesse M. Parrish will join Alliance Coal, LLC (“Alliance Coal”) as its Senior Vice President – Operations where he will be responsible for assisting with the management of our coal operations. Mr. Parrish previously served as Chief Executive Officer of Blackhawk Mining, LLC (“Blackhawk”), which produces metallurgical coal at eight mining complexes across southern West Virginia and eastern Kentucky and employs approximately 2,000 people.

“I am pleased to welcome Jesse to ARLP,” said Joseph W. Craft III, Chairman, President and Chief Executive Officer. “Jesse’s strong leadership skills, experience and expertise in the coal industry will be a valuable addition to the Alliance Coal management team as we continue to provide our customers with reliable baseload fuel to meet the significant growth in U.S. electricity demand from data centers and on-shoring of manufacturing. I look forward to working closely with him to deliver attractive returns to our unitholders.”

Prior to serving as Chief Executive Officer, Mr. Parrish held various other positions over his long career at Blackhawk, including President, Chief Financial Officer, Vice President and Director of Strategic Planning and Corporate Communications at Blackhawk. Prior to joining Blackhawk, Jesse practiced law at Bingham Greenebaum Doll LLP, where he focused on coal-related financings, mergers and acquisitions, and environmental matters. Mr. Parrish is a graduate of the University of Kentucky with a Bachelor of Business Administration in Finance and a Juris Doctor. Parrish has previously served as the chairman for the West Virginia Coal Association and the Kentucky Coal Association and is a trustee for the Energy and Mineral Law Foundation.

About Alliance Resource Partners, L.P.

ARLP is a diversified energy company that is currently the second largest coal producer in the eastern United States, supplying reliable, affordable energy domestically and internationally to major utilities, metallurgical and industrial users. ARLP also generates operating and royalty income from mineral interests it owns in strategic coal and oil & gas producing regions in the United States. In addition, ARLP is positioning itself as a reliable energy partner for the future by pursuing opportunities that support the growth and development of energy and related infrastructure.

News, unit prices and additional information about ARLP, including filings with the Securities and Exchange Commission (“SEC”), are available at www.arlp.com. For more information, contact the investor relations department of ARLP at (918) 295-7673 or via e-mail at investorrelations@arlp.com.

Contacts

Investor Relations Contact
Cary P. Marshall
Senior Vice President and Chief Financial Officer
(918) 295-7673
investorrelations@arlp.com

Release – Townsquare Announces Conference Call to Discuss First Quarter 2025 Results

Research News and Market Data on TSQ

PURCHASE, N.Y., April 14, 2025 (GLOBE NEWSWIRE) — Townsquare Media, Inc. (NYSE: TSQ) (“Townsquare” or the “Company”) announced today that it will release first quarter 2025 financial results before the market opens on Thursday, May 8, 2025. The Company will host a conference call to discuss certain first quarter 2025 financial results on Thursday, May 8, 2025 at 8:00 a.m. Eastern Time.

The conference call dial-in number is 1-800-717-1738 (U.S. & Canada) or 1-646-307-1865 (International) and the conference ID is “Townsquare.” A live webcast of the conference call as well as the press release disclosing the Company’s results will be available on the investor relations page of the Company’s website at www.townsquaremedia.com.

A telephone replay of the conference call will be available through May 15, 2025. To access the replay, please dial 1-844-512-2921 (U.S. & Canada) or 1-412-317-6671 (International) and enter confirmation code 1134601. A web-based archive of the conference call will also be available on the investor relations page of the Company’s website.

About Townsquare Media, Inc.
Townsquare is a community-focused digital and broadcast media and digital marketing solutions company principally focused outside the top 50 markets in the U.S. Townsquare Ignite, our robust digital advertising division, specializes in helping businesses of all sizes connect with their target audience through data-driven, results based strategies, by utilizing a) our proprietary digital programmatic advertising technology stack with an in-house demand and data management platform and b) our owned and operated portfolio of more than 400 local news and entertainment websites and mobile apps along with a network of leading national music and entertainment brands, collecting valuable first party data. Townsquare Interactive, our subscription digital marketing services business, partners with SMBs to help manage their digital presence by providing a SAAS business management platform, website design, creation and hosting, search engine optimization and other digital services. And through our portfolio of local radio stations strategically situated outside the Top 50 markets in the United States, we provide effective advertising solutions for our clients and relevant local content for our audiences. For more information, please visit www.townsquaremedia.comwww.townsquareinteractive.com, and www.townsquareignite.com.

Investor Relations
Claire Yenicay
(203) 900-5555
investors@townsquaremedia.com

GeoVax Labs (GOVX) – Stop Work Order Received For Project NextGen Trial – No Impact On Other Programs


Tuesday, April 15, 2025

GeoVax Labs, Inc. is a clinical-stage biotechnology company developing novel therapies and vaccines for solid tumor cancers and many of the world’s most threatening infectious diseases. The company’s lead program in oncology is a novel oncolytic solid tumor gene-directed therapy, Gedeptin®, presently in a multicenter Phase 1/2 clinical trial for advanced head and neck cancers. GeoVax’s lead infectious disease candidate is GEO-CM04S1, a next-generation COVID-19 vaccine targeting high-risk immunocompromised patient populations. Currently in three Phase 2 clinical trials, GEO-CM04S1 is being evaluated as a primary vaccine for immunocompromised patients such as those suffering from hematologic cancers and other patient populations for whom the current authorized COVID-19 vaccines are insufficient, and as a booster vaccine in patients with chronic lymphocytic leukemia (CLL). In addition, GEO-CM04S1 is in a Phase 2 clinical trial evaluating the vaccine as a more robust, durable COVID-19 booster among healthy patients who previously received the mRNA vaccines. GeoVax has a leadership team who have driven significant value creation across multiple life science companies over the past several decades.

Robert LeBoyer, Senior Vice President, Equity Research Analyst, Biotechnology, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

GeoVax Has Received A Stop Work Order For The Phase 2b Trial. GeoVax has received a Stop Work order for its BARDA-sponsored Phase 2b trial testing of CM04S1 for COVID-19. We have known about other Project NextGen-funded COVID-19 trials that were halted, but hoped the CM04S1 program would continue.

Background On The Phase 2 Trial. In June 2024, BARDA (an office within HHS) selected CM04S1 for a Phase 2b trial to test efficacy, immunogenicity, and safety for protection against COVID-19 as part of Project NexGen. We had expected GeoVax to receive about $25 million for its work on trial design and supplies to be received over several years. During FY2024, GeoVax received payments of $4.0 million.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Bit Digital (BTBT) – First Cerebras Systems Location Secured


Tuesday, April 15, 2025

Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.

Jacob Mutchler, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

New Tier 3 Site. Bit Digital announced that it has secured the rights to a new data center site in Saint-Jérôme, Québec (to be known as Montreal-3). This site, which is under development, will support the previously announced 5MW colocation agreement with Cerebras Systems, a leader in generative AI infrastructure.

Details. The facility spans approximately 202,000 square feet on 7.7 acres. In addition to the current Cerebras agreement, the facility has future expansion potential, subject to utility approvals. The transaction was executed under a lease-to-own structure, which includes a fixed-price purchase option exercisable within 12 months. The lease term is 20 years, with two 5-year extension options. The facility is being retrofitted to Tier 3 standards. Bit Digital expects development costs to total approximately CAD $55 million (approximately $40MM USD), and a targeted go-live date of July 2025.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

​StoneX’s $900M Acquisition of R.J. O’Brien: A Strategic Expansion in Global Derivatives​

Key Points:
– StoneX acquires R.J. O’Brien for $900M, expanding its client base and derivatives footprint.
– Deal brings in $766M in annual revenue and $170M in EBITDA, with $100M+ in combined synergies projected.
– Signals broader consolidation in fintech and infrastructure, opening opportunities for small-cap innovators.

StoneX Group Inc. (NASDAQ: SNEX), a diversified financial services firm with a $3 billion market cap, has entered into a definitive agreement to acquire R.J. O’Brien (RJO) — the oldest futures brokerage in the U.S. — for approximately $900 million in a transformative all-cash and stock transaction. The acquisition, announced April 14, significantly strengthens StoneX’s footprint in the global derivatives clearing and execution space, while offering intriguing ripple effects for small- and micro-cap investors active in the financial infrastructure ecosystem.

Under the terms of the deal, StoneX will pay $625 million in cash and issue 3.5 million shares of common stock to complete the acquisition. The company will also assume up to $143 million of RJO’s debt. RJO supports over 75,000 client accounts and maintains one of the largest global networks of introducing brokers, giving StoneX an immediate scale boost and access to nearly 300 new brokerage relationships.

For investors in small-cap financial services and fintech firms, this merger is significant. RJO has long held a unique niche in the derivatives space, especially in commodities, agriculture, and physical hedging markets. While both firms bring over a century of institutional knowledge, RJO’s expertise in traditional futures markets combined with StoneX’s broader capital markets reach and OTC platform suggests a diversified and potentially more competitive offering in a rapidly consolidating sector.

This deal also signals a growing appetite for consolidation in the brokerage and financial infrastructure space — an area where many micro- and small-cap firms operate. For companies building next-generation risk, trading, or clearing technology, StoneX’s deal is a reminder that established firms are actively looking for strategic expansion and complementary capabilities.

From a financial standpoint, RJO brings meaningful value. It generated $766 million in revenue and approximately $170 million in EBITDA in 2024. The deal is expected to drive more than $50 million in operating cost synergies and unlock a similar amount in capital efficiencies. The addition of nearly $6 billion in client float expands StoneX’s balance sheet flexibility and clears a path for future earnings growth.

Notably, the transaction increases StoneX’s cleared listed derivatives volume by approximately 190 million contracts annually. This positions the firm among the top global players in a highly competitive space — one where small-cap disruptors and traditional firms are constantly jostling for relevance in an evolving market landscape.

While the combined company remains a mid-cap name today, its ongoing appetite for integration and diversified revenue streams places it on the radar for long-term investors focused on scalable financial services platforms.

For small-cap investors, the real takeaway is how this deal reinforces the rising value of deep client networks, multi-asset execution, and operational scale — qualities that emerging firms must either build or partner to attain in today’s market.

Russell Reconstitution 2025: The Ultimate Guide to This Year’s Index Shake-Up

The Russell Reconstitution is an annual event where FTSE Russell recalibrates its U.S. equity indexes, such as the Russell 3000 and Russell 2000, to reflect changes in the market. This process ensures that the indexes accurately represent the current U.S. equity landscape by adjusting for shifts in company market capitalizations and other relevant factors.

Key Dates for the 2025 Reconstitution

  • April 30, 2025: Rank day—companies are ranked by market capitalization to determine index membership.
  • May 23, 2025: FTSE Russell publishes preliminary additions and deletions for the indexes.​
  • June 27, 2025: Reconstitution becomes effective after the U.S. market closes.​
  • June 30, 2025: Markets open with the newly reconstituted Russell U.S. Indexes

The Importance of the Russell 3000 Index

The Russell 3000 Index serves as a comprehensive benchmark, encompassing approximately 98% of the investable U.S. equity market. It includes the largest 3,000 U.S. companies, providing a broad view of the market’s performance.​

Spotlight on the Russell 2000 Index

The Russell 2000 Index focuses on the smallest 2,000 companies within the Russell 3000, offering insights into the small-cap segment of the market. This index is closely watched as a barometer for the performance of smaller, domestically focused companies.

IPO Additions Throughout the Year

FTSE Russell also incorporates eligible IPOs into its indexes on a quarterly basis, ensuring that newly public companies are promptly represented in the appropriate benchmarks like the Russell 3000 instead of waiting for reconstitution.

Impact on Trading Activity

The reconstitution prompts significant trading activity as index funds and ETFs adjust their holdings to align with the updated index compositions. With hundreds of billions of dollars benchmarked to Russell indexes, these adjustments can lead to substantial market movements.​

Following Russell’s Transparent Methodology

FTSE Russell employs a transparent, rules-based methodology for its reconstitution process. Key eligibility criteria include:​

  • Trading on eligible U.S. stock exchanges​
  • Meeting minimum price, market cap, and liquidity thresholds​
  • Sufficient public float and voting rights​
  • Eligible corporate structures​

Staying informed about these criteria helps investors anticipate changes that may affect their portfolios.

As the Russell indexes continue to evolve, the annual reconstitution remains a critical event for investors. Monitoring these changes can provide valuable insights into market trends and help inform investment strategies when reallocating capital.

Release – Perfect Corp. to Announce Financial Results for First Quarter of 2025 on April 28, 2025

Research News and Market Data on PERF

April 14, 2025

NEW YORK–(BUSINESS WIRE)– Perfect Corp. (NYSE: PERF) (“Perfect” or the “Company”), a global leader in providing augmented reality (“AR”) and artificial intelligence (“AI”) Software-as-a-Service (“SaaS”) solutions to beauty and fashion industries, today announced that it plans to release its financial results for the first quarter of 2025 before U.S. markets open on Monday, April 28, 2025 and to hold a conference call at 8:00 p.m. Eastern Time the same day on April 28, 2025 (or 8:00 a.m. Taipei Standard Time the following day on April 29, 2024).

The Company’s management will discuss the financial results and latest developments during the conference call. For participants who wish to join the call, please complete online registration using the link provided below in advance of the conference call. Upon registration, each participant will receive a participant dial-in number and a unique access PIN, which can be used to join the conference call.

Registration Link: https://registrations.events/direct/Q4I51630494

A live and archived webcast of the conference call will also be available at the Company’s investor relations website at https://ir.perfectcorp.com.

About Perfect Corp.
Perfect Corp. (NYSE: PERF) leverages ‘Beautiful AI’ innovations to make our world more beautiful. As a pioneer and leader in the space, Perfect Corp. works with over 650 partners around the globe to empower brands to embrace the digital-first world by transforming shopping journeys through digital tech innovations. Perfect Corp.’s suite of enterprise solutions delivers synergistic, technology-driven experiences that facilitate sustainable, ultra-personalized, and engaging shopping journeys through hyper-realistic virtual try-ons, AI-powered skin analyses, personalized product recommendation tools and many more Beautiful AI innovations. For more information, visit https://ir.perfectcorp.com/.

Category: Investor Relations

Investor Relations Contact
Investor Relations, Perfect Corp.
Email: Investor_Relations@PerfectCorp.com

Source: Perfect Corp.

Release – Alliance Resource Partners, L.P. Announces First Quarter 2025 Earnings Conference Call

Research News and Market Data on ARLP

April 14, 2025

Download(opens in new window)

TULSA, Okla.–(BUSINESS WIRE)– Alliance Resource Partners, L.P. (NASDAQ: ARLP) will report its first quarter 2025 financial results before the market opens on Monday, April 28, 2025. Alliance management will discuss these results during a conference call beginning at 10:00 a.m. Eastern that same day.

To participate in the conference call, dial U.S. Toll Free (877) 407-0784 and request to be connected to the Alliance Resource Partners, L.P. earnings conference call. International callers should dial (201) 689-8560 and request to be connected to the same call. Investors may also listen to the call via the “Investors” section of ARLP’s website at www.arlp.com.

An audio replay of the conference call will be available for approximately one week. To access the audio replay, dial U.S. Toll Free (844) 512-2921; International Toll (412) 317-6671 and request to be connected to replay using access code 13753170.

About Alliance Resource Partners, L.P.

ARLP is a diversified energy company that is currently the second largest coal producer in the eastern United States, supplying reliable, affordable energy domestically and internationally to major utilities, metallurgical and industrial users. ARLP also generates operating and royalty income from mineral interests it owns in strategic coal and oil & gas producing regions in the United States. In addition, ARLP is positioning itself as a reliable energy partner for the future by pursuing opportunities that support the growth and development of energy and related infrastructure.

News, unit prices and additional information about ARLP, including filings with the Securities and Exchange Commission (“SEC”), are available at www.arlp.com. For more information, contact the investor relations department of ARLP at (918) 295-7673 or via e-mail at investorrelations@arlp.com.

Investor Relations Contact
Cary P. Marshall
Senior Vice President and Chief Financial Officer
(918) 295-7673
investorrelations@arlp.com

Source: Alliance Resource Partners, L.P.

InPlay Oil (IPOOF) – Moving Up in the League Table


Monday, April 14, 2025

InPlay Oil is a junior oil and gas exploration and production company with operations in Alberta focused on light oil production. The company operates long-lived, low-decline properties with drilling development and enhanced oil recovery potential as well as undeveloped lands with exploration possibilities. The common shares of InPlay trade on the Toronto Stock Exchange under the symbol IPO and the OTCQX Exchange under the symbol IPOOF.

Mark Reichman, Managing Director, Equity Research Analyst, Natural Resources, Noble Capital Markets, Inc.

Hans Baldau, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Transformative acquisition closed. InPlay Oil recently closed its acquisition of Cardium light oil focused assets in the Pembina area of Alberta from Obsidian Energy for net consideration of approximately $301 million. The transaction more than doubles InPlay’s total output to 18,750 barrels of oil equivalent per day (boe/d). The assets are 68% weighted in oil and natural gas liquids (NGLs) and have a low decline rate of 22%. Management expects greater production, a lower decline rate, and enhanced operational efficiency. Following the completion of the acquisition, InPlay had 167,636,627 shares issued and outstanding.

Share consolidation. Effective April 14, InPlay will implement a share consolidation based on one common share for six common shares. The consolidation was unanimously approved by the company’s board and by 96.56% of the votes cast during a special meeting of shareholders. Post-consolidation, InPlay will have approximately 27,939,438 common shares issued and outstanding. The shares are expected to begin trading on a post-consolidation basis two to three trading days following the effective date.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision.